Status:
ACTIVE_NOT_RECRUITING
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Endometrial Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.
Eligibility Criteria
Inclusion
- Histological confirmation of endometrial cancer.
- Surgical treatment at our Gynecological - Oncology Unit.
Exclusion
- Refusal to be tested for the molecular classification
- Presence of a synchronous neoplasm.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06584630
Start Date
January 1 2022
End Date
December 31 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1st Department of Obstetrics & Gynecology, AUTh, "Papageorgiou" Hospital
Thessaloniki, Greece